Zentrum Gesundheit is the leading group for ophthalmology with then eight – currently 14 – locations in Lower Saxony and Bremen.
The eight shareholders of Zentrum Gesundheit have played a major role in the success story of their company over the last three decades. The questions the shareholders asked themselves were: How can a successful company development be continued? How can the high quality of medical services be ensured and at the same time a solution be found for a suitable gradual succession? How will this work in times of medical specialist shortage? Answering these questions was the right challenge for EUROCON.
Within a 12-month process, various succession models were developed and evaluated with all shareholders individually. After the shareholders decided to accept an investor as a new shareholder to ensure the long-term continuity of the company, various strategic and institutional potential buyers were selected and contacted. During the negotiations, the focus was mainly on the future strategy, the further integration of the current shareholders, the integration of further medical specialists as well as keeping the high medical standards. After several rounds of negotiations the clients decided in favour of Waterland Private Equity Investments.
